Disseminated on behalf of CYBN Inc (CYBN)QUARTERLY IN DEPTH ANALYSIS UPDATECYBIN INCThis communication is not an offer to buy or sell securities nor is it to be construed as personal investment advice. Nothing contained in this communication should be relied upon as a promise or representation as to future performance. As I mentioned yesterday during the Live
Avanti Helium Corp, a promising junior Helium Exploration and Production company, presents an enticing investment opportunity. This thesis aims to shed light on the factors that make Avanti Helium Corp an undervalued gem in the current market. With a strategic Midstream Deal in the pipeline, extensive due diligence on their wells (which are some of the
This quarter I am going to be covering a Biotech name that I feel, after extensive due diligence and interviewing members from the executive team (including the CEO, Doug Drysdale) is in a good position to gain additional market share and growth in the short and medium term.